Vimarsana
Biggest News Aggregation in the World

Quinolinic Acid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quinolinic Acid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quinolinic Acid Today - Breaking & Trending Today

"Quinolinic acid impairs mitophagy promoting microglia senescence and p" by Anjila Dongol, Xi Chen et al. - Vimarsana News

"Quinolinic acid impairs mitophagy promoting microglia senescence and p" by Anjila Dongol, Xi Chen et al.

Senescent microglia are a distinct microglial phenotype present in aging brain that have been implicated in the progression of aging and age-related neurodegenerative diseases. However, the specific mechanisms that trigger microglial senescence are largely unknown. Quinolinic acid (QA) is a cytotoxic metabolite produced upon abnormal activation of microglia. Brain aging and age-related neurodegenerative diseases have an elevated concentration of QA. In the present study, we investigated whether QA promotes aging and aging-related phenotypes in microglia and C. elegans. Here, we demonstrate for...

Source: uow.edu.au
Related Topics:
Quinolinic Acid
"The mechanism of quinolinic acid-induced neurite lesions: The role of " by Yuanyi Xie - Vimarsana News

"The mechanism of quinolinic acid-induced neurite lesions: The role of " by Yuanyi Xie

Increased quinolinic acid (QA) has been suggested in various mental disease pathology. Excessive QA is shown to overactivate N-Methyl-D-aspartic acid (NMDA) receptor subunit 2B (NR2B) receptors and is deleterious to the neurons; however, the exact mechanism behind this effect is complex and not fully understood. This thesis aimed to investigate the mechanism of QA-induced neurite impairment.

Source: uow.edu.au
Related Topics:
Quinolinic Acid
Relmada Therapeutics Announces Poster Presentations at the 2021 Society of Biological Psychiatry Annual Meeting - Vimarsana News

Relmada Therapeutics Announces Poster Presentations at the 2021 Society of Biological Psychiatry Annual Meeting

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...